Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (RELEVANT)

NCT01697449 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01697449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01697449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (RELEVANT)
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
March 31, 2009
Completion date
August 31, 2014
Enrollment
191 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer